Reuters logo
BRIEF-UCB announces EU approval for Vimpat as monotherapy
December 20, 2016 / 6:06 AM / a year ago

BRIEF-UCB announces EU approval for Vimpat as monotherapy

Dec 20 (Reuters) - UCB SA :

* Vimpat EU monotherapy approval

* European commission approved license extension for Vimpat (lacosamide) for use as monotherapy in treatment of partial-onset seizures in adult and adolescent patients with epilepsy

* Approval comes into immediate effect Source text: bit.ly/2gWiQEy Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below